SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-023402
Filing Date
2021-10-07
Accepted
2021-10-07 07:30:20
Documents
13
Period of Report
2021-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioli20211006_8k.htm   iXBRL 8-K 24694
  Complete submission text file 0001437749-21-023402.txt   157185

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA blfs-20211001.xsd EX-101.SCH 3593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blfs-20211001_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blfs-20211001_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blfs-20211001_pre.xml EX-101.PRE 11584
6 EXTRACTED XBRL INSTANCE DOCUMENT bioli20211006_8k_htm.xml XML 2557
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

IRS No.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 211311055
SIC: 3845 Electromedical & Electrotherapeutic Apparatus